The Value of Cancer Treatment Today

Cancer Patients Say "I'm Not Average"

PhRMA recently launched a campaign, called “I'm Not Average,” to share inspirational stories from patients about the powerful impact advances and innovations in cancer medicines have had on their lives.


What 60 Minutes Failed to Tell You about the Value and Cost of Cancer Medicines. Watch the 30 second ad that ran Sunday, October 5, 2014.

      Value

Biopharmaceutical innovation and new drug discovery delivers far-reaching benefits to patients, the U.S. health care system and our state and national economies. New cancer medicines discovered and developed by America’s biopharmaceutical research companies are helping patients lead longer, more productive lives, controlling healthcare costs and stimulating the economy through high-quality jobs and a healthier workforce.

Access

Biopharmaceutical innovation and new drug discovery delivers far-reaching benefits to patients, the U.S. health care system and our state and national economies. New cancer medicines discovered and developed by America’s biopharmaceutical research companies are helping patients lead longer, more productive lives, controlling healthcare costs and stimulating the economy through high-quality jobs and a healthier workforce.

Innovation

As one of the most research-intensive and science-driven industries in the U.S., the biopharmaceutical industry is committed to the research and development (R&D) of new treatments and cures for patients, including those who have serious unmet medical needs.

Learn about the nearly 800 cancer medicines and vaccines currently in development, and the numerous setbacks that have helped researchers improve their work and develop new treatments.


Visit PhRMA’s Innovation Hub to discover the role of innovation in improving treatment outcomes for cancer patients.


×